Kyverna Therapeutics
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Kyverna Therapeutics's balance sheet done over the years? Its assets were worth $75,195,000 last year. 35% of Kyverna Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $26,018,000.
Debt to Assets
| 2023 | 75195000 | 26.01M | 34.6% |
|---|
KYTX Balance Sheet (2023 – 2023)
| 2023 | |
|---|---|
Assets | |
Current assets: | |
Cash and cash equivalents | 34.64M |
Short term investments | 22.89M |
Net receivables | 0 |
Inventory | 0 |
Other current assets | 3.12M |
Total current assets | 60.66M |
Non-current assets: | |
Property, Plant and Equipment | 10.61M |
Goodwill | 0 |
Intangible assets | 0 |
Long term investments | 0 |
Other non-current assets | 3.92M |
Total non-current assets | 14.53M |
Total assets | 75.19M |
Liabilities | |
| Current liabilities: | |
Accounts payable | |
Deferred revenue | 0 |
Short term debt | 5.84M |
Total current liabilities | 19.85M |
| Non-current liabilities: | |
Long term debt | 6.15M |
Deferred tax | 0 |
Other non-current liabilities | 0 |
Total non-current liabilities | 6.15M |
Total liabilities | 26.01M |
| Data source |